Seeking Alpha

Neurocrine Biosciences (NBIX) drops 2.8%, to $8.40, after announcing a 9.5M share stock offering...

Neurocrine Biosciences (NBIX) drops 2.8%, to $8.40, after announcing a 9.5M share stock offering at a price of $8.10. The drug developer expects to use the proceeds to fund its R&D efforts, and for "general corporate purposes."
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs